• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR Back to Search Results
Catalog Number CDS0502
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Air Embolism (1697); Stroke/CVA (1770); Thrombosis (2100); Weakness (2145)
Event Date 11/28/2019
Event Type  Injury  
Manufacturer Narrative
Exemption number e2019001.The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of cerebrovascular accident, thrombosis, weakness and air embolism as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The investigation determined the reported paresis appears to be related to the cerebral infarction.However, a conclusive cause for the cerebral infarction, thrombus, and air embolism cannot be determined.It is possible that patient conditions contributed to cerebral infarction, thrombus, and air embolism; however, this cannot be confirmed.There is no indication of a product issue with respect to manufacture, design or labeling.
 
Event Description
This is filed to report cerebral infarction.It was reported that this was a mitraclip procedure to treat functional mitral regurgitation (mr) with a grade of 3.One mitraclip was implanted, reducing mr to <1.On (b)(6) 2019, after the patient woke from anesthesia, a cerebral infarction was confirmed with ct imaging.Paresis in the left lower limb was noted.The in the physician's opinion, a thrombus and an air embolism that occurred during the procedure could be the cause of the infarction.However, the thrombus and air embolism were not confirmed.Heparin was continued and edaravone was administered as treatment for the cerebral infarction.The paresis is almost resolved, however a light paresis of the left lower limb is still present.There was no clinically significant delay in the procedure.Hospitalization was prolonged.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key9496907
MDR Text Key175672014
Report Number2024168-2019-14759
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 12/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/30/2020
Device Catalogue NumberCDS0502
Device Lot Number90429U149
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/05/2019
Initial Date FDA Received12/19/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/30/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age71 YR
Patient Weight22
-
-